Polytetrafluorethylene (PTFE) burn characteristics and toxicant formation in an oxidizer cross-flow via laser absorption tomography. [PDF]
Sanders IC, Oberlander KA, Spearrin RM.
europepmc +1 more source
Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock +4 more
wiley +1 more source
Dynamics of Jet in Cross Flow [PDF]
S. P. Gogineni +3 more
openaire +1 more source
Cavitation suppression and transformation of turbulence structure in the cross flow around a circular cylinder: Surface morphology and wettability effects. [PDF]
Yu Nichik M +4 more
europepmc +1 more source
Cross-Flow Microfiltration of Glycerol Fermentation Broths with Citrobacter freundii. [PDF]
Tomczak W, Gryta M.
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Separation of Short-Chain Fatty Acids from Primary Sludge into a Particle-Free Permeate by Coupling Chamber Filter-Press and Cross-Flow Microfiltration: Optimization, Semi-Continuous Operation, and Evaluation. [PDF]
Shylaja Prakash N +4 more
europepmc +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +9 more
wiley +1 more source
Comprehensive Characterization of Commercial Reverse Osmosis Membranes through High-Temperature Cross-Flow Filtration. [PDF]
Karami P +10 more
europepmc +1 more source
Research of New Cross-Flow Technology with a Gas Heat Carrier for Lignite Pyrolysis. [PDF]
Fan T, Chu M, Chang Z.
europepmc +1 more source

